As of Jun 27
| -0.10 / -0.63%|
The 6 analysts offering 12-month price forecasts for Vanda Pharmaceuticals Inc have a median target of 21.50, with a high estimate of 24.00 and a low estimate of 18.00. The median estimate represents a +36.51% increase from the last price of 15.75.
The current consensus among 6 polled investment analysts is to Buy stock in Vanda Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.